Enrico Mini Selected Research

Enrico Mini Research Topics

Disease

56	Neoplasms (Cancer) 12/2023 - 04/2002
23	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 12/2002
14	Carcinoma (Carcinomatosis) 01/2022 - 01/2005
14	Ovarian Neoplasms (Ovarian Cancer) 05/2021 - 01/2003
12	Colonic Neoplasms (Colon Cancer) 01/2021 - 10/2008
7	Stomach Neoplasms (Stomach Cancer) 04/2021 - 01/2011
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 05/2010
5	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2019
4	Microsatellite Instability 12/2023 - 01/2011
4	Genomic Instability 11/2022 - 11/2017
4	Disease Progression 01/2021 - 01/2007
4	Acute Erythroblastic Leukemia (Erythroleukemia) 11/2014 - 02/2009
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2023 - 09/2014
3	Pancreatic Neoplasms (Pancreatic Cancer) 04/2023 - 01/2020
3	Neoplasm Metastasis (Metastasis) 04/2023 - 01/2018
3	Adenocarcinoma of Lung 03/2023 - 10/2018
3	Adenocarcinoma 01/2021 - 10/2015
3	Neutropenia 11/2020 - 07/2009
2	Melanoma (Melanoma, Malignant) 01/2022 - 10/2021
2	Lung Neoplasms (Lung Cancer) 10/2019 - 10/2018
2	Breast Neoplasms (Breast Cancer) 11/2012 - 01/2009
1	Prostatic Neoplasms (Prostate Cancer) 11/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2023
1	Carcinoid Tumor (Carcinoid) 01/2023
1	Ulcerative Colitis 04/2022
1	Fanconi Anemia (Fanconi's Anemia) 03/2022
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 02/2022
1	Lymphoma (Lymphomas) 01/2022
1	Polyps 12/2021
1	Adenomatous Polyps 12/2021
1	Precancerous Conditions 12/2021
1	Hepatocellular Carcinoma (Hepatoma) 11/2021

Drug/Important Bio-Agent (IBA)

16	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 12/2002
11	GoldIBA 01/2020 - 04/2002
10	Immune Checkpoint InhibitorsIBA 11/2022 - 01/2019
10	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2022 - 10/2005
10	Cisplatin (Platino)FDA LinkGeneric 03/2022 - 10/2005
8	Proteins (Proteins, Gene)FDA Link 03/2022 - 04/2011
8	Cetuximab (Erbitux)FDA Link 09/2020 - 01/2009
8	Leucovorin (Folinic Acid)FDA Link 01/2020 - 12/2002
6	Biomarkers (Surrogate Marker)IBA 12/2023 - 12/2011
6	PlatinumIBA 11/2023 - 03/2012
6	Gemcitabine FDA Link 04/2023 - 05/2010
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 02/2009
6	NivolumabIBA 10/2021 - 01/2018
5	Auranofin (Ridaura)FDA Link 01/2020 - 05/2010
4	B7-H1 AntigenIBA 12/2023 - 11/2018
4	LigandsIBA 04/2019 - 09/2006
4	Gold CompoundsIBA 11/2017 - 05/2010
4	pirarubicinIBA 11/2014 - 02/2009
3	Calcibiotic Root Canal SealerIBA 05/2023 - 08/2008
3	130-nm albumin-bound paclitaxelIBA 04/2023 - 01/2020
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2022 - 11/2017
3	Messenger RNA (mRNA)IBA 03/2021 - 09/2005
3	Drug CombinationsIBA 08/2020 - 08/2015
3	Irinotecan (Camptosar)FDA LinkGeneric 12/2011 - 07/2009
2	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 03/2022
2	Rituximab (Mabthera)FDA Link 01/2022 - 09/2014
2	Prednisone (Sone)FDA LinkGeneric 01/2022 - 09/2014
2	Vincristine (Oncovin)FDA LinkGeneric 01/2022 - 09/2014
2	AntibodiesIBA 01/2022 - 12/2014
2	AntigensIBA 01/2022 - 12/2014
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 09/2014
2	Formaldehyde (Formol)FDA Link 03/2021 - 02/2021
2	ParaffinIBA 03/2021 - 02/2021
2	Trastuzumab (Herceptin)FDA Link 01/2021 - 01/2009
2	trifluridine tipiracil drug combinationIBA 08/2020 - 01/2019
2	cabozantinibIBA 05/2020 - 09/2019
2	RNA (Ribonucleic Acid)IBA 11/2019 - 01/2007
2	SolutionsIBA 04/2019 - 12/2014
2	ErbB Receptors (EGF Receptor)IBA 11/2018 - 01/2009
2	carbeneIBA 06/2018 - 03/2014
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 03/2018 - 11/2017
2	EnzymesIBA 03/2018 - 11/2017
2	artemisinin (artemisinine)IBA 01/2016 - 04/2014
2	Liposomes (Liposome)IBA 01/2016 - 04/2014
2	Thymidylate SynthaseIBA 09/2011 - 09/2005
2	Complementary DNA (cDNA)IBA 01/2007 - 01/2005
2	Antineoplastic Agents (Antineoplastics)IBA 09/2006 - 04/2002
1	AndrogensIBA 11/2023
1	TransferasesIBA 04/2023
1	Alkaline PhosphataseIBA 04/2023
1	AfatinibIBA 03/2023
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2023
1	PlasticsIBA 01/2023
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2023
1	Tumor Biomarkers (Tumor Markers)IBA 11/2022
1	enfortumab vedotinIBA 01/2022
1	Immunoconjugates (Immunoconjugate)IBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 12/2021
1	Tyrosine Kinase InhibitorsIBA 11/2021
1	lenvatinibIBA 11/2021
1	pembrolizumabIBA 10/2021

Therapy/Procedure

27	Therapeutics 11/2023 - 01/2009
24	Drug Therapy (Chemotherapy) 11/2023 - 09/2005
10	Adjuvant Chemotherapy 03/2021 - 12/2002
7	Immunotherapy 01/2022 - 10/2018
2	Precision Medicine 05/2023 - 02/2022
1	Castration 11/2023
1	Restorative Proctocolectomy 04/2022